[go: up one dir, main page]

Follow
Alok Joglekar
Alok Joglekar
Verified email at pitt.edu
Title
Cited by
Cited by
Year
Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells
NK Kurrey, SP Jalgaonkar, AV Joglekar, AD Ghanate, PD Chaskar, ...
Stem cells 27 (9), 2059-2068, 2009
7972009
Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment
MJ Bender, AC McPherson, CM Phelps, SP Pandey, CR Laughlin, ...
Cell 186 (9), 1846-1862. e26, 2023
5462023
Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells
MD Hoban, GJ Cost, MC Mendel, Z Romero, ML Kaufman, AV Joglekar, ...
Blood, The Journal of the American Society of Hematology 125 (17), 2597-2604, 2015
4102015
T cell antigen discovery via signaling and antigen-presenting bifunctional receptors
AV Joglekar, MT Leonard, JD Jeppson, M Swift, G Li, S Wong, S Peng, ...
Nature methods 16 (2), 191-198, 2019
1872019
T cell antigen discovery via trogocytosis
G Li, MT Bethune, S Wong, AV Joglekar, MT Leonard, JK Wang, JT Kim, ...
Nature methods 16 (2), 183-190, 2019
1822019
Site-specific gene editing of human hematopoietic stem cells for X-linked hyper-IgM syndrome
CY Kuo, JD Long, B Campo-Fernandez, S de Oliveira, AR Cooper, ...
Cell reports 23 (9), 2606-2616, 2018
1572018
T cell antigen discovery
AV Joglekar, G Li
Nature methods 18 (8), 873-880, 2021
1482021
Pseudotyped lentiviral vectors: one vector, many guises
AV Joglekar, S Sandoval
Human Gene Therapy Methods 28 (6), 291-301, 2017
1332017
Personalized T cell-mediated cancer immunotherapy: progress and challenges
MT Bethune, AV Joglekar
Current opinion in biotechnology 48, 142-152, 2017
1052017
Integrase-defective lentiviral vectors as a delivery platform for targeted modification of adenosine deaminase locus
AV Joglekar, RP Hollis, G Kuftinec, S Senadheera, R Chan, DB Kohn
Molecular Therapy 21 (9), 1705-1717, 2013
822013
The beta cell-immune cell interface in type 1 diabetes (T1D)
EA James, AV Joglekar, AK Linnemann, HA Russ, SC Kent
Molecular Metabolism 78, 101809, 2023
622023
T cell receptors for the HIV KK10 epitope from patients with differential immunologic control are functionally indistinguishable
AV Joglekar, Z Liu, JK Weber, Y Ouyang, JD Jeppson, WJ Noh, ...
Proceedings of the National Academy of Sciences 115 (8), 1877-1882, 2018
332018
Alternative splicing coupled with transcript degradation modulates OAS1g antiviral activity
L Frankiw, M Mann, G Li, A Joglekar, D Baltimore
Rna 26 (2), 126-136, 2020
272020
SLIDE: significant latent factor interaction discovery and exploration across biological domains
J Rahimikollu, H Xiao, AE Rosengart, ABI Rosen, T Tabib, PM Zdinak, ...
Nature methods 21 (5), 835-845, 2024
242024
Dissecting the mechanism of histone deacetylase inhibitors to enhance the activity of zinc finger nucleases delivered by integrase-defective lentiviral vectors
AV Joglekar, L Stein, M Ho, MD Hoban, RP Hollis, DB Kohn
Human Gene Therapy 25 (7), 599-608, 2014
242014
People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden
AR Cillo, A Somasundaram, F Shan, C Cardello, CJ Workman, GD Kitsios, ...
Cell Reports Medicine 2 (12), 2021
222021
De novo identification of CD4+ T cell epitopes
PM Zdinak, N Trivedi, S Grebinoski, J Torrey, EZ Martinez, S Martinez, ...
Nature Methods 21 (5), 846-856, 2024
192024
Temporal dynamics and genomic programming of plasma cell fates
GK Manakkat Vijay, M Zhou, K Thakkar, A Rothrauff, AS Chawla, D Chen, ...
Nature immunology 25 (6), 1097-1109, 2024
172024
Signaling and antigen-presenting bifunctional receptors (sabr)
AV Joglekar, MT Leonard, MT Bethune, D Baltimore
172019
Immunopeptidomics for autoimmunity: unlocking the chamber of immune secrets
S Arshad, B Cameron, AV Joglekar
npj Systems Biology and Applications 11 (1), 10, 2025
142025
The system can't perform the operation now. Try again later.
Articles 1–20